A detailed history of Black Rock Inc. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,146,873 shares of PLSE stock, worth $18.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,146,873
Previous 1,044,808 9.77%
Holding current value
$18.1 Million
Previous $9.1 Million 41.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.69 - $14.54 $682,814 - $1.48 Million
102,065 Added 9.77%
1,146,873 $12.8 Million
Q1 2024

May 10, 2024

SELL
$7.8 - $11.02 $210,038 - $296,746
-26,928 Reduced 2.51%
1,044,808 $9.1 Million
Q4 2023

Feb 13, 2024

BUY
$3.85 - $12.84 $405,431 - $1.35 Million
105,307 Added 10.9%
1,071,736 $13.1 Million
Q3 2023

Nov 13, 2023

BUY
$4.03 - $8.73 $180,290 - $390,554
44,737 Added 4.85%
966,429 $3.89 Million
Q2 2023

Aug 11, 2023

BUY
$3.67 - $8.64 $2.56 Million - $6.02 Million
696,871 Added 309.97%
921,692 $6.63 Million
Q1 2023

May 12, 2023

BUY
$2.48 - $3.88 $2,782 - $4,353
1,122 Added 0.5%
224,821 $755,000
Q4 2022

Feb 13, 2023

BUY
$1.73 - $2.89 $1,294 - $2,161
748 Added 0.34%
223,699 $619,000
Q3 2022

Nov 14, 2022

SELL
$1.23 - $2.3 $1,150 - $2,150
-935 Reduced 0.42%
222,951 $513,000
Q2 2022

Aug 12, 2022

SELL
$1.48 - $4.28 $915,357 - $2.65 Million
-618,485 Reduced 73.42%
223,886 $343,000
Q1 2022

May 12, 2022

SELL
$4.21 - $14.79 $45,278 - $159,066
-10,755 Reduced 1.26%
842,371 $4.09 Million
Q4 2021

Feb 10, 2022

BUY
$14.78 - $24.4 $156,283 - $258,005
10,574 Added 1.25%
853,126 $12.6 Million
Q3 2021

Nov 09, 2021

SELL
$17.25 - $26.63 $692,484 - $1.07 Million
-40,144 Reduced 4.55%
842,552 $18.2 Million
Q2 2021

Aug 11, 2021

BUY
$16.31 - $23.64 $14.4 Million - $20.9 Million
882,696 New
882,696 $14.5 Million

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $585M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.